Author

Sylvie Hébrard

Centre National de la Recherche ScientifiqueORCID 0009-0005-1664-2598Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:scRNA-seq· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Bastien GerbyiD· 2 shared Christine DidieriD· 2 shared Cyril BroccardoiD· 2 shared Éric DelabesseiD· 2 shared Laëtitia LargeaudiD· 2 shared Marlène PasquetiD· 2 shared Mathieu BouttieriD· 2 shared Naïs PradeiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Bastien GerbyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintJul 3, 2026

USP7 maintains hematopoietic stem cell dormancy and function by stabilizing HMGA2

Antoine Nouhaud, Diaz Anna, Mathieu Bouttier…·Christine Didier

This study identifies USP7 as a regulator of hematopoietic stem cell dormancy by stabilizing HMGA2, showing its role in maintaining stem cell function and longevity.

DOI 10.64898/2026.07.03.731117

mousescRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 18, 2025

Targeting glucocorticoid-induced CD20 activation in preclinical models of B-ALL

Jérémy Bigot, Mathieu Bouttier, Vincent Fregona…·Bastien Gerby

This study identifies CD20 as an actionable target in B-ALL MRD using PDX models and single-cell RNA sequencing, showing anti-CD20 antibodies can eradicate drug-resistant cells.

DOI 10.64898/2025.12.16.694550

humanscRNA-seq

𝕏 PostBluesky